Breadcrumb

What's New at the RI-MUHC ?

Harnessing the body’s power in fight against cancer

Immunotherapy has provided lung cancer patients with real hope of recovery

Team from RI-MUHC and Lunenfeld-Tanenbaum Research Institute “follow a gut feeling” and discover a new stem cell

The human body has a remarkable ability to repair and renew itself. However, as we all know, our regenerative capacity quickly dwindles once we reach adulthood.

Children in Quebec are not diagnosed early enough with type 1 diabetes

A study reveals a rise in the number of children presenting a life-threatening complication at diagnosis.

The unanticipated early origins of childhood brain cancer

Canadian researchers identify earliest traces of brain cancer long before the disease becomes symptomatic

Maternal gestational diabetes linked to diabetes in children

Children of mothers who had gestational diabetes during pregnancy could be at increased risk of type 1 diabetes themselves

Increase in children and teens seen in ERs for suicide attempts and suicidal thoughts

Lead study author and RI-MUHC researcher Brett Burstein reports an alarming rise in suicidal behaviour over the last decade

Predicting Breast Cancer Metastasis to the Lung and Liver with Biomarkers

RI-MUHC researcher Peter Siegel and research associate Sébastien Tabariès have identified a key component of breast cancer metastasis to the liver and lung

Anti-TB drugs can increase risk of TB re-infection

Treatment leads to changes in gut microbiota, compromising immunity

Call for expressions of interest: Executive Director and Chief Scientific Officer, Research Institute of the McGill University Health Centre (RI-MUHC)

The RI-MUHC is seeking a dynamic and strategic leader to serve as its next Executive Director and Chief Scientific Officer (ED/CSO).

Using laser light to study how epilepsy arises in the healthy brain

Scientists at the RI-MUHC have developed a new method to study how seizures arise in the healthy brain.

Learn more about the RI-MUHC